Paccasassi Robert 4
4 · BioRestorative Therapies, Inc. · Filed Oct 31, 2018
Insider Transaction Report
Form 4
Paccasassi Robert
VP, Quality and Compliance
Transactions
- Award
Stock Option
2018-10-29+50,000→ 50,000 totalExercise: $1.23Exp: 2028-10-29→ Common Stock (50,000 underlying)
Holdings
- 5,000
Stock Option
Exercise: $4.70Exp: 2025-08-13→ Common Stock (5,000 underlying) - 15,000
Stock Option
Exercise: $3.73Exp: 2026-06-10→ Common Stock (15,000 underlying) - 40,000
Stock Option
Exercise: $2.80Exp: 2027-07-12→ Common Stock (40,000 underlying)
Footnotes (4)
- [F1]The option is exercisable to the extent of 1,667 shares on each of August 13, 2016 and August 13, 2017, and 1,666 shares on August 13, 2018.
- [F2]The option is exercisable to the extent of 5,000 shares on each of June 10, 2017, June 10, 2018 and June 10, 2019.
- [F3]The option is exercisable to the extent of 13,334 shares on July 12, 2018, and 13,333 shares on each of July 12, 2019 and July 12, 2020.
- [F4]The option is exercisable to the extent of 16,667 shares on each of October 29, 2019 and October 29, 2020, and 16,666 shares on October 29, 2021.